oral glp 1 drugs in development Lilly is now pharma's top revenue company. It just got FDA approval for an GLP-1, but Wall Street isn't celebrating GLP-1 Receptor Agonist Market Size
Description
HARMONY or discord in cardiovascular outcome trials of GLP-1 receptor agonists
- Third-party tested for quality & purity
Some of the early concern came from people I respected, including Peter Attia, who flagged lean-mass loss on scans in his own practice
Liraglutide alleviates experimental diabetic cardiomyopathy in a PDH-dependent manner
Gandhi NA, Bennett BL, Graham NM, Pirozzi G, Stahl N, Yancopoulos GD
Curr Diabetes Rep (2018) 18(7):45
